We started our activity in 2004 with the first GMP approved facility consisting of two production lines: one for sterile solutions/suspensions (eye drops) and the second for non sterile solutions/suspensions (oral drops, nasal drops/spray, topic solution/spray). The production capacity of these two lines allows the release of 30 million units per year. Because of increasing market demands, Rompharm Company had purchased high technology equipments achieving the production capacity of 64 million units yearly.

In September 2006 we put into operation the second GMP approved facility for solid dosed forms. Our state of the art equipment allows us to produce powders, granules or pellets conditioned in capsules, sachets or bottles (dry syrups).

To further extend our product range in December 2007 we had started the third facility for injection solutions aseptically produced, with a capacity of 100 million ampoules per year.

Rompharm Company gladly announces the commissioning of its new state of the art facility for manufacturing of prefilled syringes and solutions for perfusion

The prefilled syringes line with an output of more than 100 million units per year is suitable for a wide range of filling volumes ranging from 0.3ml to 20ml.

The line for perfusions in glass containers with an output of more than 20 million units per year manages volumes ranging from 2ml to 250ml.